European Medicines Agency closes PIM project
NewsMedicines
The European Medicines Agency announced the closure of the PIM project today.
The PIM (Product Information Management) project was established to increase the efficiency of the management and exchange of product information (summary of product characteristics, package leaflet and labelling) through the structuring of the information and its exchange by electronic means.
The Agency and its partners have demonstrated significant commitment to the PIM project over the years, however the Agency is currently undertaking a review of its business strategy and information-technology system requirements in the context of new legislation and a budgetary review. As a result, it has decided to halt the PIM project.
The Agency remains committed to the concept of structured product information and the efficient exchange of information. It will return to the issue once the review process has been completed.